AdamEphraimMD(He/Him)

PubMed

• 46 citations
  Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
  Myrna Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, Leandra Cole, Athalia Rachel Pyzer
  British Journal of Haematology. 2019-03-03
• 11 citations
  MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism.
  Dina Stroopinsky, Hasan Rajabi, Myrna Nahas, Jacalyn Rosenblatt, Maryam Rahimian
  Journal of Cellular and Molecular Medicine. 2018-05-15
• 5 citations
  Personalized tumor vaccine for pancreatic cancer.
  Shira Orr, Ling Huang, James Moser, Dina Stroopinsky, Omar Gandarilla
  Cancer Immunology, Immunotherapy. 2023-02-01

Abstracts/Posters

• Impact of area deprivation index on clinical outcomes of adults with acute myeloid leukemia at a rural academic medical center
  Jordan L. Edgren, Adam Ephraim, John P. Palmer, Mohadeseh Kazemi, Todd MacKenzie, Frederick Lansigan, Jonathan P. Pirruccello, Liying Pan, Odeth Barrett-Campbell, Swar..., Journal of Clinical Oncology, 5/31/2023
• Phase I/Ib Trial of the MUC1 Inhibitor GO-203-2C Alone and in Combination with Decitabine for Acute Myeloid Leukemia
  Jessica Liegel MD, Jacalyn Rosenblatt MD, Malgorzata McMasters MD, James D. Levine MD MS, Myrna Nahas MD, Robin M. Joyce MD, Salvia Jain MD, Daniel J. DeAngelo MD, Jac..., Blood, Volume 130, Supplement 1, 2017, Page 2659, ISSN 0006-4971, https://doi.org/10.1182/blood.V130.Suppl_1.2659.2659., 12/7/2017
• Hypomethylating Agent Leads to Enhanced Immunogenicity of a Dendritic Cell/Acute Myeloid Leukemia Fusion Vaccine and Prolonged Survival in an Immunocompetent Mouse Model
  Myrna R. Nahas, MD, Leandra Cole, Dina Stroopinsky, PhD, Anna Sergeeva, PhD, Athalia Rachel Pyzer, MD PhD, Abigail J. Washington, Malgorzata McMasters, MD, James D. Le..., Blood (2017) 130 (Supplement 1): 1347. https://doi.org/10.1182/blood.V130.Suppl_1.1347.1347, 12/7/2017